SHL Telemedicine Ltd. (SWX:SHLTN)
Switzerland · Delayed Price · Currency is CHF 1.100
+0.030 (2.80%)
Jan 30, 2026, 5:30 PM CET
SHL Telemedicine Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 56.83 | 56.78 | 57.08 | 59 | 49.58 | 40.16 | |
Revenue Growth (YoY) | 1.59% | -0.52% | -3.26% | 18.99% | 23.45% | -4.11% |
Cost of Revenue | 31.11 | 30.99 | 31.81 | 31.81 | 24.99 | 19.52 |
Gross Profit | 25.72 | 25.79 | 25.26 | 27.19 | 24.59 | 20.64 |
Selling, General & Admin | 26.73 | 27.5 | 26.81 | 28.15 | 21.56 | 16.94 |
Research & Development | 5.09 | 5.36 | 5.26 | 3.79 | 2.99 | 2.76 |
Other Operating Expenses | 2.14 | 1.6 | 0.96 | 0.42 | -0.16 | 0.5 |
Operating Expenses | 33.96 | 34.46 | 33.03 | 32.36 | 24.38 | 20.2 |
Operating Income | -8.24 | -8.67 | -7.77 | -5.17 | 0.21 | 0.44 |
Interest Expense | -1.49 | -1.12 | -1.3 | -1.03 | -0.53 | -0.41 |
Interest & Investment Income | - | 0.72 | 1.06 | 0.43 | 0.38 | 0.1 |
Currency Exchange Gain (Loss) | 0.16 | 0.16 | 0.99 | 0.61 | -1.59 | 0.05 |
Other Non Operating Income (Expenses) | -0.34 | -0.34 | 1.44 | 0.06 | -0.99 | -0.22 |
EBT Excluding Unusual Items | -9.91 | -9.25 | -5.58 | -5.1 | -2.52 | -0.03 |
Merger & Restructuring Charges | -1.75 | -1.75 | -1.24 | - | -0.59 | - |
Impairment of Goodwill | -13.45 | -13.45 | - | - | - | - |
Gain (Loss) on Sale of Investments | 0.56 | 0.56 | 0.85 | -0.77 | -0.11 | 0.16 |
Asset Writedown | -2.93 | -2.93 | - | - | -0.12 | -0.05 |
Other Unusual Items | - | - | - | 7.18 | -10.13 | - |
Pretax Income | -27.48 | -26.81 | -5.96 | 1.31 | -13.47 | 0.08 |
Income Tax Expense | 0.73 | 0.94 | 0.89 | 1.1 | 0.46 | -0.2 |
Earnings From Continuing Operations | -28.21 | -27.75 | -6.86 | 0.22 | -13.92 | 0.28 |
Minority Interest in Earnings | -0.23 | -0.34 | -0.2 | -0.29 | -0.19 | - |
Net Income | -28.44 | -28.1 | -7.06 | -0.08 | -14.11 | 0.28 |
Net Income to Common | -28.44 | -28.1 | -7.06 | -0.08 | -14.11 | 0.28 |
Net Income Growth | - | - | - | - | - | -95.12% |
Shares Outstanding (Basic) | 16 | 16 | 16 | 15 | 14 | 11 |
Shares Outstanding (Diluted) | 16 | 16 | 16 | 15 | 14 | 11 |
Shares Change (YoY) | -3.46% | 0.59% | 7.22% | 7.71% | 34.33% | 0.01% |
EPS (Basic) | -1.77 | -1.71 | -0.43 | -0.01 | -1.00 | 0.03 |
EPS (Diluted) | -1.77 | -1.71 | -0.54 | -0.49 | -1.00 | 0.03 |
EPS Growth | - | - | - | - | - | -95.10% |
Free Cash Flow | -2.99 | -1.32 | -2.79 | -1.73 | -0.44 | 3.82 |
Free Cash Flow Per Share | -0.19 | -0.08 | -0.17 | -0.11 | -0.03 | 0.36 |
Gross Margin | 45.25% | 45.43% | 44.26% | 46.09% | 49.60% | 51.40% |
Operating Margin | -14.51% | -15.26% | -13.61% | -8.76% | 0.43% | 1.10% |
Profit Margin | -50.05% | -49.48% | -12.36% | -0.13% | -28.46% | 0.69% |
Free Cash Flow Margin | -5.27% | -2.33% | -4.88% | -2.94% | -0.89% | 9.52% |
EBITDA | -6.26 | -6.24 | -5.4 | -2.43 | 4.35 | 4.14 |
EBITDA Margin | -11.01% | -10.99% | -9.46% | -4.12% | 8.77% | 10.30% |
D&A For EBITDA | 1.99 | 2.43 | 2.37 | 2.74 | 4.14 | 3.69 |
EBIT | -8.24 | -8.67 | -7.77 | -5.17 | 0.21 | 0.44 |
EBIT Margin | -14.51% | -15.26% | -13.61% | -8.76% | 0.43% | 1.10% |
Effective Tax Rate | - | - | - | 83.61% | - | - |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.